BANK VONTOBEL/CALL/MEDTRONIC/92/0.1/20.12.24 Share Price

Warrant

DE000VD3SU71

Real-time Boerse Frankfurt Warrants 01:59:06 01/07/2024 pm IST
0.084 EUR +12.00% Intraday chart for BANK VONTOBEL/CALL/MEDTRONIC/92/0.1/20.12.24
1 month-50.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
01/24/01 0.084 +12.00%
28/24/28 0.075 +25.00%
27/24/27 0.06 -24.05%
26/24/26 0.079 -4.82%
25/24/25 0.083 -17.00%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 01:59 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SU7
ISINDE000VD3SU71
Date issued 09/04/2024
Strike 92 $
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.32
Lowest since issue 0.06
Delta0.17x
Omega 14.28
Premium18.1x
Gearing82.28x
Moneyness 0.8555
Difference Strike 13.29 $
Difference Strike %+14.45%
Spread 0.01
Spread %10.64%
Theoretical value 0.0890
Implied Volatility 20.19 %
Total Loss Probability 85.85 %
Intrinsic value 0.000000
Present value 0.0890
Break even 92.96 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus